82 Percent of Employees with Panic Attacks Find Relief With Digital Therapeutic Study in Journal of Mental Health and Clinic Psychology Confirms Freespira Drastically Reduces Panic Disorder Severity News provided by Share this article KIRKLAND, Wash., April 28, 2021 /PRNewswire/ -- Freespira, Inc., the maker of the first FDA-cleared digital therapeutic to significantly reduce or eliminate symptoms of panic attacks, panic disorder (PD) and post-traumatic stress disorder (PTSD) in only 28 days, today announced that the Journal of Mental Health and Clinical Psychology published data demonstrating that PD severity can be significantly reduced with its first-of-its-kind treatment. Crossover Health conducted the study with eligible employees at its Midtown, New York City health center.